175 related articles for article (PubMed ID: 13358564)
21. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan].
FRAENKEL KA; SCHULZ K
Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175
[No Abstract] [Full Text] [Related]
22. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
KLOTZBUCHER E
Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
[No Abstract] [Full Text] [Related]
23. [Hypoglycemic and antidiabetic effects of N-(t-butylthiodiazol-yl)sulfanilamide].
LOUBATIERES A
C R Hebd Seances Acad Sci; 1956 Jul; 243(4):420-1. PubMed ID: 13343625
[No Abstract] [Full Text] [Related]
24. [Pharmacological action of a new oral antidiabetic drug].
PELLEGRINI R
Boll Soc Ital Biol Sper; 1956; 32(1-2):67-9. PubMed ID: 13374024
[No Abstract] [Full Text] [Related]
25. An oral drug for diabetes.
O'DRISCOLL BJ
J Ir Med Assoc; 1956 Oct; 39(232):106-9. PubMed ID: 13367545
[No Abstract] [Full Text] [Related]
26. D 860, a new antidiabetic remedy.
HEIKINHEIMO R
Duodecim; 1957; 73(1):53-5. PubMed ID: 13427681
[No Abstract] [Full Text] [Related]
27. [Diabetes mellitus and current therapy].
DEROT M; RATHERY M
Gaz Med Fr; 1957 Mar; 64(6):555-64. PubMed ID: 13427961
[No Abstract] [Full Text] [Related]
28. Effects of carbutamide in the diabetes associated with acromegaly.
FEDERMAN DD; FIELD JB
Diabetes; 1957; 6(1):70-2; discussion, 85-90. PubMed ID: 13397430
[No Abstract] [Full Text] [Related]
29. [Invenol massive therapy of diabetes mellitus].
SCHMITT-HALIN E
Med Klin; 1957 May; 52(21):899-901. PubMed ID: 13440521
[No Abstract] [Full Text] [Related]
30. The oral treatment of diabetes mellitus.
DRURY MI; WOLANCZYK WJ
J Ir Med Assoc; 1956 Oct; 39(232):100-5. PubMed ID: 13367544
[No Abstract] [Full Text] [Related]
31. Metabolic effects of carbutamide in selected diabetics.
BASTENIE PA; FRANCKSON JR; DE MEUTTER R; DEMANET TC; CONARD V
Lancet; 1957 Mar; 272(6967):504-7. PubMed ID: 13407049
[No Abstract] [Full Text] [Related]
32. [Ambulatory treatment of diabetes mellitus with 1-p-amino-benzenesulfonyl 3-n-butyl urea].
MILANI G; PADOVAN D
Policlinico Prat; 1956 Sep; 63(37):1305-11. PubMed ID: 13379039
[No Abstract] [Full Text] [Related]
33. Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide).
ANDERSON RC; KIRTLEY WR; RIDOLFO AS; ROOT MA
Diabetes; 1956; 5(5):351-7. PubMed ID: 13365474
[No Abstract] [Full Text] [Related]
34. [Oral therapy of diabetes mellitus with sulfamide derivatives].
WILTNER W
Orv Hetil; 1956 Sep; 97(39):1081-4. PubMed ID: 13388338
[No Abstract] [Full Text] [Related]
35. The oral treatment of diabetes mellitus with invenol.
CHILDERS R; SYNGE VM
J Ir Med Assoc; 1956 Oct; 39(232):112. PubMed ID: 13367547
[No Abstract] [Full Text] [Related]
36. Clinical trial of invenol in diabetes mellitus.
DOOLIN M; MACCORMAC M; O'DONOVAN DK
J Ir Med Assoc; 1956 Oct; 39(232):93-9. PubMed ID: 13367543
[No Abstract] [Full Text] [Related]
37. [Resistance to oral Diabetes Therapy?].
ENGELHARD H
Medizinische; 1956 Nov; 1(46):1639-41. PubMed ID: 13386741
[No Abstract] [Full Text] [Related]
38. The arylsulfonylureas and diabetes mellitus.
LLOYD CW
J Clin Endocrinol Metab; 1956 Dec; 16(12):1626-8. PubMed ID: 13385311
[No Abstract] [Full Text] [Related]
39. [Peroral treatment of diabetes. I].
KUHLMANN F
Med Klin; 1956 Nov; 51(44):1878-81. PubMed ID: 13386825
[No Abstract] [Full Text] [Related]
40. Metabolic effects of carbutamide in diabetes and interrelations with glucagon; a preliminary report.
IZZO JL
Diabetes; 1957; 6(1):45-53; discussion, 62. PubMed ID: 13397422
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
